The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global HPV Therapeutic Vaccines Market Research Report 2025
Synopsis
Human papilloma virus (HPV) vaccines are used to protect against HPV infections.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The global HPV Therapeutic Vaccines market was valued at US$ 4401 million in 2023 and is anticipated to reach US$ 12480 million by 2030, witnessing a CAGR of 15.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for HPV Therapeutic Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HPV Therapeutic Vaccines.
Report Scope
The HPV Therapeutic Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HPV Therapeutic Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HPV Therapeutic Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co., Inc
GlaxoSmithKline plc
Shanghai Bovax Biotechnology Co., Ltd.
Profectus BioSciences, Inc.
2A Pharma AB
ISA Pharmaceuticals
Pfizer
Sanofi Pasteur
Serum Institute
Emergent BioSolutions
Astellas Pharma
Johnson and Johnson.
Wantai BioPharm
INOVIO Pharmaceuticals
Segment by Type
Bivalent HPV vaccine
Quadrivalent HPV vaccine
Segment by Application
Man
Woman
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HPV Therapeutic Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Human papilloma virus (HPV) vaccines are used to protect against HPV infections.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The global HPV Therapeutic Vaccines market was valued at US$ 4401 million in 2023 and is anticipated to reach US$ 12480 million by 2030, witnessing a CAGR of 15.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for HPV Therapeutic Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HPV Therapeutic Vaccines.
Report Scope
The HPV Therapeutic Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HPV Therapeutic Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HPV Therapeutic Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co., Inc
GlaxoSmithKline plc
Shanghai Bovax Biotechnology Co., Ltd.
Profectus BioSciences, Inc.
2A Pharma AB
ISA Pharmaceuticals
Pfizer
Sanofi Pasteur
Serum Institute
Emergent BioSolutions
Astellas Pharma
Johnson and Johnson.
Wantai BioPharm
INOVIO Pharmaceuticals
Segment by Type
Bivalent HPV vaccine
Quadrivalent HPV vaccine
Segment by Application
Man
Woman
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HPV Therapeutic Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HPV Therapeutic Vaccines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bivalent HPV vaccine
1.2.3 Quadrivalent HPV vaccine
1.3 Market by Application
1.3.1 Global HPV Therapeutic Vaccines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Man
1.3.3 Woman
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HPV Therapeutic Vaccines Market Perspective (2019-2030)
2.2 HPV Therapeutic Vaccines Growth Trends by Region
2.2.1 Global HPV Therapeutic Vaccines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HPV Therapeutic Vaccines Historic Market Size by Region (2019-2024)
2.2.3 HPV Therapeutic Vaccines Forecasted Market Size by Region (2025-2030)
2.3 HPV Therapeutic Vaccines Market Dynamics
2.3.1 HPV Therapeutic Vaccines Industry Trends
2.3.2 HPV Therapeutic Vaccines Market Drivers
2.3.3 HPV Therapeutic Vaccines Market Challenges
2.3.4 HPV Therapeutic Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HPV Therapeutic Vaccines Players by Revenue
3.1.1 Global Top HPV Therapeutic Vaccines Players by Revenue (2019-2024)
3.1.2 Global HPV Therapeutic Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global HPV Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HPV Therapeutic Vaccines Revenue
3.4 Global HPV Therapeutic Vaccines Market Concentration Ratio
3.4.1 Global HPV Therapeutic Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HPV Therapeutic Vaccines Revenue in 2023
3.5 HPV Therapeutic Vaccines Key Players Head office and Area Served
3.6 Key Players HPV Therapeutic Vaccines Product Solution and Service
3.7 Date of Enter into HPV Therapeutic Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HPV Therapeutic Vaccines Breakdown Data by Type
4.1 Global HPV Therapeutic Vaccines Historic Market Size by Type (2019-2024)
4.2 Global HPV Therapeutic Vaccines Forecasted Market Size by Type (2025-2030)
5 HPV Therapeutic Vaccines Breakdown Data by Application
5.1 Global HPV Therapeutic Vaccines Historic Market Size by Application (2019-2024)
5.2 Global HPV Therapeutic Vaccines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HPV Therapeutic Vaccines Market Size (2019-2030)
6.2 North America HPV Therapeutic Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HPV Therapeutic Vaccines Market Size by Country (2019-2024)
6.4 North America HPV Therapeutic Vaccines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HPV Therapeutic Vaccines Market Size (2019-2030)
7.2 Europe HPV Therapeutic Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HPV Therapeutic Vaccines Market Size by Country (2019-2024)
7.4 Europe HPV Therapeutic Vaccines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HPV Therapeutic Vaccines Market Size (2019-2030)
8.2 Asia-Pacific HPV Therapeutic Vaccines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HPV Therapeutic Vaccines Market Size by Region (2019-2024)
8.4 Asia-Pacific HPV Therapeutic Vaccines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HPV Therapeutic Vaccines Market Size (2019-2030)
9.2 Latin America HPV Therapeutic Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HPV Therapeutic Vaccines Market Size by Country (2019-2024)
9.4 Latin America HPV Therapeutic Vaccines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HPV Therapeutic Vaccines Market Size (2019-2030)
10.2 Middle East & Africa HPV Therapeutic Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2019-2024)
10.4 Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co., Inc
11.1.1 Merck & Co., Inc Company Detail
11.1.2 Merck & Co., Inc Business Overview
11.1.3 Merck & Co., Inc HPV Therapeutic Vaccines Introduction
11.1.4 Merck & Co., Inc Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.1.5 Merck & Co., Inc Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Detail
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc HPV Therapeutic Vaccines Introduction
11.2.4 GlaxoSmithKline plc Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Shanghai Bovax Biotechnology Co., Ltd.
11.3.1 Shanghai Bovax Biotechnology Co., Ltd. Company Detail
11.3.2 Shanghai Bovax Biotechnology Co., Ltd. Business Overview
11.3.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Introduction
11.3.4 Shanghai Bovax Biotechnology Co., Ltd. Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.3.5 Shanghai Bovax Biotechnology Co., Ltd. Recent Development
11.4 Profectus BioSciences, Inc.
11.4.1 Profectus BioSciences, Inc. Company Detail
11.4.2 Profectus BioSciences, Inc. Business Overview
11.4.3 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Introduction
11.4.4 Profectus BioSciences, Inc. Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.4.5 Profectus BioSciences, Inc. Recent Development
11.5 2A Pharma AB
11.5.1 2A Pharma AB Company Detail
11.5.2 2A Pharma AB Business Overview
11.5.3 2A Pharma AB HPV Therapeutic Vaccines Introduction
11.5.4 2A Pharma AB Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.5.5 2A Pharma AB Recent Development
11.6 ISA Pharmaceuticals
11.6.1 ISA Pharmaceuticals Company Detail
11.6.2 ISA Pharmaceuticals Business Overview
11.6.3 ISA Pharmaceuticals HPV Therapeutic Vaccines Introduction
11.6.4 ISA Pharmaceuticals Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.6.5 ISA Pharmaceuticals Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer HPV Therapeutic Vaccines Introduction
11.7.4 Pfizer Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Sanofi Pasteur
11.8.1 Sanofi Pasteur Company Detail
11.8.2 Sanofi Pasteur Business Overview
11.8.3 Sanofi Pasteur HPV Therapeutic Vaccines Introduction
11.8.4 Sanofi Pasteur Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.8.5 Sanofi Pasteur Recent Development
11.9 Serum Institute
11.9.1 Serum Institute Company Detail
11.9.2 Serum Institute Business Overview
11.9.3 Serum Institute HPV Therapeutic Vaccines Introduction
11.9.4 Serum Institute Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.9.5 Serum Institute Recent Development
11.10 Emergent BioSolutions
11.10.1 Emergent BioSolutions Company Detail
11.10.2 Emergent BioSolutions Business Overview
11.10.3 Emergent BioSolutions HPV Therapeutic Vaccines Introduction
11.10.4 Emergent BioSolutions Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.10.5 Emergent BioSolutions Recent Development
11.11 Astellas Pharma
11.11.1 Astellas Pharma Company Detail
11.11.2 Astellas Pharma Business Overview
11.11.3 Astellas Pharma HPV Therapeutic Vaccines Introduction
11.11.4 Astellas Pharma Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.11.5 Astellas Pharma Recent Development
11.12 Johnson and Johnson.
11.12.1 Johnson and Johnson. Company Detail
11.12.2 Johnson and Johnson. Business Overview
11.12.3 Johnson and Johnson. HPV Therapeutic Vaccines Introduction
11.12.4 Johnson and Johnson. Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.12.5 Johnson and Johnson. Recent Development
11.13 Wantai BioPharm
11.13.1 Wantai BioPharm Company Detail
11.13.2 Wantai BioPharm Business Overview
11.13.3 Wantai BioPharm HPV Therapeutic Vaccines Introduction
11.13.4 Wantai BioPharm Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.13.5 Wantai BioPharm Recent Development
11.14 INOVIO Pharmaceuticals
11.14.1 INOVIO Pharmaceuticals Company Detail
11.14.2 INOVIO Pharmaceuticals Business Overview
11.14.3 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Introduction
11.14.4 INOVIO Pharmaceuticals Revenue in HPV Therapeutic Vaccines Business (2019-2024)
11.14.5 INOVIO Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global HPV Therapeutic Vaccines Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bivalent HPV vaccine
Table 3. Key Players of Quadrivalent HPV vaccine
Table 4. Global HPV Therapeutic Vaccines Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global HPV Therapeutic Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global HPV Therapeutic Vaccines Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global HPV Therapeutic Vaccines Market Share by Region (2019-2024)
Table 8. Global HPV Therapeutic Vaccines Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global HPV Therapeutic Vaccines Market Share by Region (2025-2030)
Table 10. HPV Therapeutic Vaccines Market Trends
Table 11. HPV Therapeutic Vaccines Market Drivers
Table 12. HPV Therapeutic Vaccines Market Challenges
Table 13. HPV Therapeutic Vaccines Market Restraints
Table 14. Global HPV Therapeutic Vaccines Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global HPV Therapeutic Vaccines Market Share by Players (2019-2024)
Table 16. Global Top HPV Therapeutic Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HPV Therapeutic Vaccines as of 2023)
Table 17. Ranking of Global Top HPV Therapeutic Vaccines Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by HPV Therapeutic Vaccines Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players HPV Therapeutic Vaccines Product Solution and Service
Table 21. Date of Enter into HPV Therapeutic Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global HPV Therapeutic Vaccines Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global HPV Therapeutic Vaccines Revenue Market Share by Type (2019-2024)
Table 25. Global HPV Therapeutic Vaccines Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global HPV Therapeutic Vaccines Revenue Market Share by Type (2025-2030)
Table 27. Global HPV Therapeutic Vaccines Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global HPV Therapeutic Vaccines Revenue Market Share by Application (2019-2024)
Table 29. Global HPV Therapeutic Vaccines Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global HPV Therapeutic Vaccines Revenue Market Share by Application (2025-2030)
Table 31. North America HPV Therapeutic Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America HPV Therapeutic Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America HPV Therapeutic Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe HPV Therapeutic Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe HPV Therapeutic Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe HPV Therapeutic Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific HPV Therapeutic Vaccines Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific HPV Therapeutic Vaccines Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific HPV Therapeutic Vaccines Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America HPV Therapeutic Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America HPV Therapeutic Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America HPV Therapeutic Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa HPV Therapeutic Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 46. Merck & Co., Inc Company Detail
Table 47. Merck & Co., Inc Business Overview
Table 48. Merck & Co., Inc HPV Therapeutic Vaccines Product
Table 49. Merck & Co., Inc Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 50. Merck & Co., Inc Recent Development
Table 51. GlaxoSmithKline plc Company Detail
Table 52. GlaxoSmithKline plc Business Overview
Table 53. GlaxoSmithKline plc HPV Therapeutic Vaccines Product
Table 54. GlaxoSmithKline plc Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 55. GlaxoSmithKline plc Recent Development
Table 56. Shanghai Bovax Biotechnology Co., Ltd. Company Detail
Table 57. Shanghai Bovax Biotechnology Co., Ltd. Business Overview
Table 58. Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Product
Table 59. Shanghai Bovax Biotechnology Co., Ltd. Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 60. Shanghai Bovax Biotechnology Co., Ltd. Recent Development
Table 61. Profectus BioSciences, Inc. Company Detail
Table 62. Profectus BioSciences, Inc. Business Overview
Table 63. Profectus BioSciences, Inc. HPV Therapeutic Vaccines Product
Table 64. Profectus BioSciences, Inc. Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 65. Profectus BioSciences, Inc. Recent Development
Table 66. 2A Pharma AB Company Detail
Table 67. 2A Pharma AB Business Overview
Table 68. 2A Pharma AB HPV Therapeutic Vaccines Product
Table 69. 2A Pharma AB Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 70. 2A Pharma AB Recent Development
Table 71. ISA Pharmaceuticals Company Detail
Table 72. ISA Pharmaceuticals Business Overview
Table 73. ISA Pharmaceuticals HPV Therapeutic Vaccines Product
Table 74. ISA Pharmaceuticals Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 75. ISA Pharmaceuticals Recent Development
Table 76. Pfizer Company Detail
Table 77. Pfizer Business Overview
Table 78. Pfizer HPV Therapeutic Vaccines Product
Table 79. Pfizer Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Sanofi Pasteur Company Detail
Table 82. Sanofi Pasteur Business Overview
Table 83. Sanofi Pasteur HPV Therapeutic Vaccines Product
Table 84. Sanofi Pasteur Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 85. Sanofi Pasteur Recent Development
Table 86. Serum Institute Company Detail
Table 87. Serum Institute Business Overview
Table 88. Serum Institute HPV Therapeutic Vaccines Product
Table 89. Serum Institute Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 90. Serum Institute Recent Development
Table 91. Emergent BioSolutions Company Detail
Table 92. Emergent BioSolutions Business Overview
Table 93. Emergent BioSolutions HPV Therapeutic Vaccines Product
Table 94. Emergent BioSolutions Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 95. Emergent BioSolutions Recent Development
Table 96. Astellas Pharma Company Detail
Table 97. Astellas Pharma Business Overview
Table 98. Astellas Pharma HPV Therapeutic Vaccines Product
Table 99. Astellas Pharma Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 100. Astellas Pharma Recent Development
Table 101. Johnson and Johnson. Company Detail
Table 102. Johnson and Johnson. Business Overview
Table 103. Johnson and Johnson. HPV Therapeutic Vaccines Product
Table 104. Johnson and Johnson. Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 105. Johnson and Johnson. Recent Development
Table 106. Wantai BioPharm Company Detail
Table 107. Wantai BioPharm Business Overview
Table 108. Wantai BioPharm HPV Therapeutic Vaccines Product
Table 109. Wantai BioPharm Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 110. Wantai BioPharm Recent Development
Table 111. INOVIO Pharmaceuticals Company Detail
Table 112. INOVIO Pharmaceuticals Business Overview
Table 113. INOVIO Pharmaceuticals HPV Therapeutic Vaccines Product
Table 114. INOVIO Pharmaceuticals Revenue in HPV Therapeutic Vaccines Business (2019-2024) & (US$ Million)
Table 115. INOVIO Pharmaceuticals Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HPV Therapeutic Vaccines Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global HPV Therapeutic Vaccines Market Share by Type: 2023 VS 2030
Figure 3. Bivalent HPV vaccine Features
Figure 4. Quadrivalent HPV vaccine Features
Figure 5. Global HPV Therapeutic Vaccines Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global HPV Therapeutic Vaccines Market Share by Application: 2023 VS 2030
Figure 7. Man Case Studies
Figure 8. Woman Case Studies
Figure 9. HPV Therapeutic Vaccines Report Years Considered
Figure 10. Global HPV Therapeutic Vaccines Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global HPV Therapeutic Vaccines Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global HPV Therapeutic Vaccines Market Share by Region: 2023 VS 2030
Figure 13. Global HPV Therapeutic Vaccines Market Share by Players in 2023
Figure 14. Global Top HPV Therapeutic Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HPV Therapeutic Vaccines as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by HPV Therapeutic Vaccines Revenue in 2023
Figure 16. North America HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America HPV Therapeutic Vaccines Market Share by Country (2019-2030)
Figure 18. United States HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe HPV Therapeutic Vaccines Market Share by Country (2019-2030)
Figure 22. Germany HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific HPV Therapeutic Vaccines Market Share by Region (2019-2030)
Figure 30. China HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America HPV Therapeutic Vaccines Market Share by Country (2019-2030)
Figure 38. Mexico HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa HPV Therapeutic Vaccines Market Share by Country (2019-2030)
Figure 42. Turkey HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia HPV Therapeutic Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Merck & Co., Inc Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 45. GlaxoSmithKline plc Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 46. Shanghai Bovax Biotechnology Co., Ltd. Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 47. Profectus BioSciences, Inc. Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 48. 2A Pharma AB Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 49. ISA Pharmaceuticals Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 50. Pfizer Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 51. Sanofi Pasteur Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 52. Serum Institute Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 53. Emergent BioSolutions Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 54. Astellas Pharma Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 55. Johnson and Johnson. Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 56. Wantai BioPharm Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 57. INOVIO Pharmaceuticals Revenue Growth Rate in HPV Therapeutic Vaccines Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
